Welcome to our dedicated page for Radnet news (Ticker: RDNT), a resource for investors and traders seeking the latest updates and insights on Radnet stock.
RadNet, Inc. reports recurring developments in outpatient diagnostic imaging, digital health, and radiology technology. The company operates owned and managed imaging centers that provide MRI, CT, PET/CT, mammography, ultrasound, X-ray, fluoroscopy, nuclear medicine, and related procedures for physicians and patients across U.S. markets.
RadNet news commonly covers financial results, imaging-center procedure volumes, guidance updates, joint ventures, acquisitions, and customer or technology collaborations. Its Digital Health segment includes DeepHealth, which provides radiology information technology, AI-powered health informatics, clinical AI applications, patient engagement tools, operational AI, teleradiology services, and related products for the diagnostic imaging industry.
RadNet (NASDAQ: RDNT) entered Incremental Amendment No. 3 to its first lien credit agreement, adding a $250 million incremental term loan maturing April 18, 2031 alongside the existing $958.7 million term loan.
Quarterly principal rises to about $3.1 million, while interest rates on the Term Loan and undrawn $282 million revolver are reduced by 0.25%. Proceeds are expected to fund acquisitions, organic growth, health system partnerships and other corporate purposes, adding to a $455 million cash balance as of March 31, 2026.
DeepHealth, a RadNet (NASDAQ: RDNT) subsidiary, launched Reporting Pro, an AI-powered radiology reporting platform now commercially available in the US and UK. The solution unifies speech recognition, clinical AI findings, measurements, AI-generated impressions, quality assurance and structured reporting into one workflow.
Reporting Pro integrates FDA-cleared and CE-marked AI tools, uses generative AI to draft impressions, and is designed to work with any PACS and RIS. It is being deployed across RadNet and with initial external customers, and supports all major imaging modalities.
RadNet (NASDAQ: RDNT) plans to secure a $200 million incremental term loan under an amendment to its First Lien Credit and Guaranty Agreement. The new loan would form part of its existing term loan and mature on April 18, 2031.
Proceeds are expected to support acquisitions, organic expansion, health system partnerships and general corporate purposes, giving RadNet added flexibility for strategic growth. Completion of the loan transaction is subject to customary market and other conditions.
RadNet (NASDAQ: RDNT) will host a free public Men’s Health webinar on Saturday, June 13, 2026, during National Men’s Health Month.
Leading radiologists will discuss coronary artery disease, prostate cancer and lung cancer, focusing on risk factors, screening criteria and the role of diagnostic imaging in early detection.
RadNet (NASDAQ: RDNT) reported record first quarter 2026 results, with revenue up 22.1% to $575.6 million and Adjusted EBITDA(1) up 36.3% to $63.3 million. Digital Health revenue grew 51.5% to $29.1 million and ARR(4) rose to $96.9 million.
Advanced imaging volumes increased 19.7% systemwide. Adjusted diluted loss per share(3) improved to $(0.28). RadNet raised 2026 Imaging Center guidance for revenue to $2.355–$2.405 billion, Adjusted EBITDA(1) to $340–$353 million, and Free Cash Flow(2) to $112–$122 million, and reaffirmed all Digital Health guidance ranges.
RadNet (NASDAQ: RDNT) formed a joint venture with Saint Alphonsus Health System by acquiring a majority equity stake in Intermountain Medical Imaging, owner of five outpatient multimodality imaging centers in Boise, Idaho.
RadNet will manage operations, Gem State Radiology will continue professional services with ~30 radiologists, and the centers will deploy DeepHealth clinical, reporting, AI and operations suites. The joint venture is projected to generate approximately $30 million in annual revenue.
RadNet (NASDAQ: RDNT) will host a conference call to discuss its first quarter 2026 financial results on Monday, May 11, 2026 at 7:30 a.m. PT (10:30 a.m. ET). Investors may join by phone or listen to simultaneous and archived webcasts.
Dial-in, international numbers, webcast link, and replay passcode are provided for live participation and later access.
GE HealthCare (Nasdaq: GEHC) expanded its collaboration with DeepHealth (RadNet subsidiary) to commercially extend DeepHealth’s AI-powered Breast Suite internationally and integrate new applications with GE’s Pristina Via mammography systems. The deal adds ProFound Pro, Safeguard Review, and cloud-first workflow tools to scale AI-enabled breast cancer screening and second‑reader workflows.
RadNet (NASDAQ: RDNT) announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will present at the KeyBanc Capital Markets Healthcare Forum on March 17, 2026 at 4:30 p.m. ET (1:30 p.m. PT). Live and archived webcasts are available at the provided webcast link.
RadNet (NASDAQ: RDNT) announced that CFO Mark Stolper will present at the 28th Annual Barclays Global Healthcare Conference on Thursday, March 12, 2026 at 8:00 a.m. ET / 5:00 a.m. PT.
A live webcast and archived replay will be available, and the in-person presentation is scheduled at Loews Miami Beach Hotel.